Zevra Therapeutics (NASDAQ:ZVRA) Price Target Raised to $22.00
Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its target price boosted by Guggenheim from $20.00 to $22.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reiterated a “buy” rating […]
Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its target price boosted by Guggenheim from $20.00 to $22.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reiterated a “buy” rating […]
